Literature DB >> 32204750

[Standardized management guideline for pediatric wards of hematology and oncology during the epidemic of coronavirus disease 2019].

.   

Abstract

With the spread of coronavirus disease 2019 (COVID-19) and growing knowledge of its diagnosis and treatment, it has been clear that children are also susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The children with hematological tumors are a special population with immunosuppression and special therapeutic characteristics. Here the management guideline for pediatric wards of hematology and oncology during COVID-19 epidemic is established based on the features of children with hematological tumors.

Entities:  

Mesh:

Year:  2020        PMID: 32204750      PMCID: PMC7389601     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  3 in total

1.  [Recommendations for the diagnosis, prevention and control of the 2019 novel coronavirus infection in children (first interim edition)].

Authors: 
Journal:  Zhonghua Er Ke Za Zhi       Date:  2020-03-02

2.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

3.  [Recommendation for the diagnosis and treatment of novel coronavirus infection in children in Hubei (Trial version 1)].

Authors: 
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-02
  3 in total
  1 in total

1.  COVID-19 in pediatric oncology from French pediatric oncology and hematology centers: High risk of severe forms?

Authors:  Nicolas André; Jérémie Rouger-Gaudichon; Benoît Brethon; Aurélie Phulpin; Éric Thébault; Sophie Pertuisel; Virginie Gandemer
Journal:  Pediatr Blood Cancer       Date:  2020-05-08       Impact factor: 3.838

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.